InvestorsHub Logo
Followers 29
Posts 2176
Boards Moderated 0
Alias Born 12/13/2016

Re: kld2 post# 105911

Monday, 05/22/2017 5:25:35 PM

Monday, May 22, 2017 5:25:35 PM

Post# of 458524
Kid, Not to prolong this line of discussion but today's announcement means the 2-73 is being studied critically by outside unbiased sources. The Rett, Fragil X and Angelman Foundations have scientific staffs that conduct numerous preclinical studies on possible drugs which may help their patient populations. The safety profile from our P2 and their studies, coupled with "potential" human efficacy is a positive start for human trials. Phase 2 trials even if they only continue to prove 2-73 safety are steps forward. The three Foundations' preclinical results show 2-73's "potential" to exceed current SOCs. The best part is that the Foundations would fund human trials.

The most hopeful aspect is we may contribute to reducing suffering of these children.

Talon
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News